high
social
medic
need
better
understand
human
lung
diseas
lower
respiratori
tract
infect
chronic
obstruct
pulmonari
diseas
copd
lung
cancer
tuberculosi
belong
ten
common
caus
death
studi
analyz
global
burden
pneumonia
estim
million
episod
occur
children
younger
year
around
million
progress
sever
pneumonia
caus
million
furthermor
studi
estim
global
burden
copd
year
identifi
million
case
among
urban
dweller
million
among
rural
dweller
worldwid
therebi
provid
overview
high
preval
lung
diseas
addit
diseas
asthma
also
affect
million
peopl
worldwid
show
likewis
increas
preval
although
mortal
due
asthma
decreas
last
decad
cur
therapi
avail
person
constraint
daili
life
activ
lung
cancer
still
lead
caus
death
model
accur
reflect
human
lung
cancer
could
help
aid
understand
derang
signal
network
help
identifi
valid
new
potenti
therapi
taken
togeth
high
global
burden
lung
diseas
rang
econom
individu
prerequisit
understand
diseas
identifi
novel
treatment
option
creation
valid
complex
model
multipl
readout
option
better
mimic
physiolog
tissu
accur
reflect
clinic
situat
one
could
argu
use
immort
cell
line
anim
model
rodent
reveal
essenti
inform
understand
treat
human
lung
diseas
doubt
techniqu
approach
help
make
major
contribut
field
scientif
commun
increasingli
recogn
model
outcom
suffer
seriou
limit
estim
potenti
therapeut
deem
safe
effect
anim
fail
human
due
studi
design
rais
ethic
concern
regard
sacrif
anim
well
patient
receiv
ineffect
agent
potenti
moreov
lung
anatomi
cellular
composit
molecular
respons
man
significantli
differ
wide
use
anim
model
instanc
chronic
bronchiti
copd
character
excess
mucu
product
howev
contrast
human
bronchial
gland
mice
rat
anatom
local
proxim
trachea
make
difficult
reproduc
particular
diseas
parallel
challeng
current
attempt
simul
effect
cigarett
smoke
air
pollut
lung
cancer
induct
anim
model
limit
multipl
way
basic
therefor
vigor
debat
arisen
last
decad
regard
predict
valu
mous
model
inflammatori
diseas
across
mani
diseas
context
anoth
intrigu
exampl
need
use
primari
human
lung
sampl
emerg
zoonot
infect
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
new
influenza
viru
iav
pandem
sever
anim
model
natur
permiss
sever
infect
need
viru
adapt
anim
host
serial
passag
therebi
affect
viral
pathogen
anim
model
often
need
transgen
express
human
receptor
eg
human
angiotensin
convert
enzym
sar
coronaviru
cov
human
dipeptidyl
peptidas
mer
cov
simpli
reflect
clinic
cours
diseas
furthermor
inher
characterist
zoonosi
specif
occurr
distinct
anim
speci
human
host
speci
specif
factor
mostli
unknown
factor
pathogen
host
determin
zoonot
axi
therefor
investig
fundament
factor
defin
pathogen
cross
speci
barrier
must
includ
materi
infect
model
zoonot
partner
speci
mean
local
context
human
although
complex
human
lung
tissu
model
suffer
physiolog
limit
obvious
purpos
make
effort
toward
analyz
fundament
lung
biolog
origin
tissu
interest
tissu
use
mimic
variou
diseas
even
elabor
analyz
diseas
tissu
biopsi
serv
model
addit
current
establish
human
vitro
model
requir
improv
exampl
cultur
bronchial
lung
epithelia
cell
lack
cilia
hardli
form
tight
junction
typic
express
vivo
observ
interfac
thu
need
recapitul
complex
structur
matrix
lung
tissu
suitabl
cell
establish
appropri
intercellular
besid
integr
model
human
clonal
primari
cell
use
dissect
fundament
aspect
biolog
singl
lung
cell
popul
vitro
indispens
complement
understand
speci
specif
signal
pathway
conclus
high
medic
need
togeth
fundament
methodolog
consider
substanti
necess
develop
diseas
model
acut
chronic
lung
diseas
purpos
recent
develop
techniqu
allow
innov
meaning
investig
human
lung
tissu
review
outlin
exampl
model
applic
develop
date
discuss
direct
improv
use
human
lung
tissu
shown
review
approv
ethic
committe
charit
berlin
project
written
inform
consent
patient
obtain
last
decad
tissu
engin
approach
made
tremend
progress
sever
vitro
model
studi
inhal
toxic
diseas
establish
aim
improv
understand
physiolog
process
provid
novel
reliant
experiment
system
pharmacolog
toxicolog
studi
current
vitro
lung
model
import
segment
respiratori
system
avail
start
nasal
caviti
trachea
proxim
distal
cell
cultur
model
human
lung
epithelium
base
either
primari
cell
includ
normal
human
trachea
bronchial
epitheli
cell
nh
bec
aec
induc
pluripot
stem
cell
ipsc
deriv
epitheli
gener
use
cell
line
ipsc
deriv
epitheli
cell
organoid
patient
lung
diseas
cystic
fibrosi
cell
manipul
vitro
gene
edit
recent
shown
recapitul
function
known
derang
human
lung
diseas
ipsc
deriv
lung
bud
organoid
also
recent
use
studi
respiratori
syncyti
viral
model
thu
provid
opportun
identifi
new
treatment
understand
underli
biolog
human
diseas
commonli
use
lung
epitheli
cell
line
cell
line
offer
sever
advantag
primari
cell
almost
unlimit
cell
sourc
passag
howev
suffer
distinct
limit
lack
mucu
product
absent
tight
junction
format
induc
cell
differenti
cell
typic
cultur
biocompat
scaffold
matric
mimic
natur
environ
matric
consist
natur
eg
collagen
gelatin
elastin
algin
silk
synthet
compound
eg
polyglycol
acid
polylact
acid
polyethylen
glycol
polyvinyl
alcohol
polyacryl
acid
import
step
improv
physiolog
relev
model
cultur
lung
epitheli
cell
ali
sinc
increas
oxygen
air
exposur
play
crucial
role
develop
bronchial
epitheli
cell
cultur
ali
condit
develop
epithelium
compris
basal
cell
well
ciliat
surfac
cell
goblet
cell
wherea
submerg
cultur
express
substanti
fewer
ciliat
addit
ali
cultur
offer
opportun
direct
applic
aerosol
solid
particl
onto
cell
surfac
close
resembl
vivo
situat
kept
cultur
sever
addit
use
primari
immort
cell
model
normal
cell
biolog
tumor
model
use
human
cell
becom
import
tool
cancer
research
complex
depend
object
research
question
tumor
model
develop
provid
insight
eg
tumor
growth
invas
matrix
remodel
drug
deliveri
mani
lung
tumor
studi
use
spheroid
model
therapeut
screen
cluster
cell
undergo
form
viabl
structur
spheroid
gener
use
low
attach
extracellular
matric
matrigeltm
rotatori
cell
cultur
system
hang
drop
hang
drop
use
produc
spheroid
better
reflect
vivo
condit
cancer
cell
investig
eg
cultur
time
depend
cell
type
experiment
question
small
spheroid
use
drug
test
larg
recapitul
oxygen
gradient
hypox
region
prolifer
gradient
complex
model
lung
cancer
tumor
establish
serv
tool
identifi
new
drug
target
decellular
tissu
matrix
deriv
rodent
lung
recellular
human
lung
cancer
cell
line
provid
perfus
tumor
altern
collagen
gel
base
model
describ
contain
human
lung
adenocarcinoma
cell
human
lung
fibroblast
cell
sever
research
group
establish
airway
model
pulmonari
research
consist
undifferenti
nhtbbiliari
epitheli
cell
bec
besid
use
well
character
fulli
differenti
standard
human
airway
model
commerci
avail
offer
major
advantag
higher
data
reproduc
due
lower
variabl
model
use
wide
rang
applic
includ
safeti
risk
assess
research
eg
new
compound
drug
deliveri
system
common
lung
diseas
inflamm
fibrosi
mattek
corp
usa
epithelix
suiss
compos
normal
nhtbbec
epithelium
mimick
sever
patholog
like
asthma
copd
cystic
fibrosi
also
obtain
epithelix
suiss
human
lung
cancer
model
combin
function
reconstitut
human
airway
epithelium
human
lung
fibroblast
lung
adenocarcinoma
cell
use
drug
efficaci
test
toxic
effect
analyz
tumor
recurr
major
advantag
model
abil
cultur
exampl
use
lifetim
month
wherea
cultiv
month
allow
repeat
toxic
efficaci
studi
main
disadvantag
commerci
model
lack
complex
abil
custom
particular
applic
regard
model
offer
flexibl
particularli
regard
cell
select
cell
manipul
like
genet
modif
via
gene
knockdown
moreov
endotheli
cell
implement
mimic
model
dendrit
cell
andor
macrophag
gener
immunocompet
tissu
allow
detail
studi
lung
implement
immun
cell
howev
challeng
approach
requir
extens
research
effort
develop
reliabl
predict
model
close
resembl
vivo
situat
besid
modif
includ
cell
popul
model
area
improv
applic
physic
forc
motion
cultur
system
benam
et
present
system
human
lung
bronchial
epitheli
cell
healthi
individu
asthma
copd
patient
differenti
ali
cultur
grown
extracellular
matrix
ecm
coat
dimethylsiloxan
membran
integr
microfluid
system
cultur
human
endotheli
cell
lower
side
endotheli
channel
perfus
cultur
medium
cultur
airway
cell
combin
applic
stimul
agent
via
airflow
perfus
channel
via
vascular
rout
allow
great
varieti
function
studi
includ
eg
recruit
immun
cell
bloodstream
airway
group
use
experiment
setup
model
alveolar
region
integr
flexibl
membran
two
side
hollow
chamber
induc
stretch
epitheli
cell
grown
upper
side
endotheli
cell
grown
bottom
side
membran
therebi
simul
breath
motion
lung
notabl
model
human
alveolar
cell
expos
airstream
thu
cultur
ali
condit
alia
system
commerci
emul
inc
boston
usa
thu
may
avail
futur
rang
applic
end
varieti
human
model
differ
complex
base
vitro
cultur
lung
cell
avail
besid
develop
variou
vitro
model
mimick
upper
lower
human
respiratori
tract
ex
vivo
cultur
human
lung
tissu
enabl
broad
spectrum
investig
dynam
context
nativ
structur
especi
alveolar
compart
benefit
control
experiment
condit
well
represent
natur
patient
heterogen
earli
studi
use
direct
snap
frozen
homogen
human
lung
tissu
specimen
analyt
determin
molecular
antibiot
pathogen
howev
experiment
approach
exclud
ex
vivo
lung
model
discuss
due
lack
ex
vivo
cultiv
stimul
major
tissu
explant
studi
literatur
base
tissu
piec
obtain
thorac
surgeri
mostli
due
differ
type
lung
carcinoma
addit
complet
lobectomi
pneumonectomi
explant
well
whole
lung
unsuit
transplant
use
due
limit
experi
techniqu
avail
cell
cultur
initi
studi
investig
human
lung
tissu
cultur
sever
hour
salin
media
eg
identif
mediat
releas
coloni
stimul
although
limit
short
time
tissu
cultur
possibl
group
austen
et
al
alreadi
abl
investig
role
histamin
anaphylaxi
seri
eleg
studi
therebi
indic
power
experiment
current
follow
patholog
examin
tissu
typic
transfer
research
unit
within
hour
manual
prepar
smaller
piec
differ
size
weight
g
occur
cultur
time
lung
tissu
explant
gener
precis
cut
lung
slice
pcl
obtain
tissu
gentli
inflat
lung
slice
medium
compos
cultiv
medium
certain
supplement
low
melt
point
agaros
latter
allow
product
lung
section
defin
thick
use
microtom
eg
krumdieck
tissu
slicer
vibratom
depend
size
weight
gener
specimen
cultiv
tissu
cultur
plate
vari
size
tissu
cultur
flask
appropri
amount
classic
cell
cultur
medium
mem
one
week
cultur
media
supplement
differ
consider
research
group
vari
amount
antibiot
antifung
drug
glutamin
fetal
calf
serum
bovin
serum
albumin
use
studi
typic
tissu
wash
sever
time
cultur
media
follow
overnight
incub
stimul
eg
drug
pathogen
stimuli
interest
laboratori
particularli
interest
respons
larger
airway
thu
explor
bronchial
ring
prepar
lung
tissu
specimen
appli
similar
cultur
condit
peripher
lung
parenchyma
howev
studi
investig
use
shorter
period
bronchial
ring
cultiv
eg
day
studi
test
peripher
alveolar
lung
tissu
cultur
human
bronchial
ring
special
organ
chamber
coupl
mechan
electr
field
allow
investig
classic
physiolog
respons
bronchi
bronchoconstrict
consequ
mani
studi
focus
eg
pharmacolog
intervent
identif
bronchial
substanc
small
number
group
investig
isol
ex
vivo
perfus
ventil
human
lung
model
lung
tissu
perfus
via
cannul
pulmonari
arteri
cell
free
perfus
media
eg
dilut
whole
human
blood
prepar
solut
lung
preserv
transport
lung
ventil
via
natur
airway
h
limit
avail
technic
elabor
model
allow
investig
lung
edema
oxygen
capac
vascular
reactiv
bacteri
innov
therapeut
approach
stem
cell
exampl
demonstr
multipl
scalabl
approach
differ
complex
use
live
human
lung
tissu
origin
tissu
architectur
experiment
research
test
new
clinic
intervent
recent
use
acellular
lung
tissu
also
refer
decellular
emerg
novel
vitroex
vivo
model
system
studi
ecm
interact
context
normal
diseas
repair
regener
acellular
lung
scaffold
shown
retain
uniqu
individu
protein
composit
well
differ
comprehens
assess
mass
spectrometri
proteom
addit
normal
lung
lung
deriv
scleroderma
idiopath
pulmonari
fibrosi
ipf
copd
patient
decellular
date
shown
maintain
characterist
composit
structur
respect
diseas
patholog
acellular
lung
scaffold
gener
entir
lung
individu
lobe
segment
modif
might
necessari
decellular
diseas
entir
lung
individu
lobe
decellular
achiev
via
perfus
decellular
solut
deterg
hypohyperton
solut
dnase
either
vasculatur
vasculatur
airway
decellular
scaffold
recellular
either
primari
stem
progenitor
induc
pluripot
stem
cell
ip
immort
cell
line
sinc
recellular
entir
lobe
costli
gener
three
techniqu
use
cell
acellular
lung
scaffold
common
method
gener
thin
slice
decellular
tissu
follow
direct
applic
method
arguabl
simplest
perform
allow
high
throughput
studi
singl
acellular
scaffold
howev
suffer
fact
cell
seed
two
dimens
initi
cell
seed
thought
stochast
eg
cell
randomli
attach
upper
surfac
slice
document
prefer
adher
physiolog
compart
correspond
cell
vivo
locat
altern
cell
suspens
inject
dissect
decellular
tissu
segment
process
thin
segment
slice
cell
inner
portion
scaffold
limit
access
nutrient
oxygen
third
high
throughput
method
recellular
allow
physiolog
seed
cell
either
airway
vascular
compart
artifici
primari
human
fibroblast
seed
acellular
lung
scaffold
deriv
patient
ipf
found
obtain
myofibroblast
phenotyp
assess
muscl
actin
follow
studi
determin
matrix
cell
seed
play
signific
role
determin
cell
fate
sourc
cell
ie
normal
versu
ipf
immort
cell
human
fibroblast
also
seed
onto
normal
acellular
human
scaffold
stimul
recombin
prototyp
chitinas
like
protein
induc
express
contractil
addit
usag
ipf
research
acellular
lung
scaffold
deriv
copd
patient
also
use
cell
seed
onto
copd
scaffold
unabl
surviv
long
scaffold
deriv
normal
cell
grown
condit
known
stimul
prolifer
two
dimens
tissu
cultur
plastic
indic
either
matrix
compon
matrixscaffold
suppress
prolifer
enhanc
cell
death
instanc
find
vitro
match
known
hallmark
human
diseas
howev
import
note
mass
spectrometri
proteom
consist
detect
larg
number
compon
acellular
human
lung
scaffold
normal
diseas
origin
mani
growth
factor
known
involv
diseas
onset
therefor
acellular
scaffold
result
experi
view
model
interact
interpret
model
extracellular
environ
normal
diseas
lung
includ
matrix
sequest
growth
factor
abil
recapitul
heterogen
human
diseas
vivo
like
environ
make
acellular
human
lung
scaffold
power
vitro
tool
studi
human
diseas
ex
vivo
model
character
rel
short
cultur
period
research
thu
concentr
use
system
investig
rapid
second
hour
within
day
respons
asthma
research
pcl
use
extens
investig
new
drug
intervent
interf
bronchial
noteworthi
care
done
studi
point
remark
differ
mice
respect
regul
bronchial
although
costli
enorm
import
estim
potenti
translat
impact
studi
use
mice
model
asthma
research
scientif
journal
often
adequ
honor
work
use
human
materi
model
alon
mani
studi
use
ali
explant
human
lung
investig
lung
tissu
infect
inflamm
exampl
work
assess
viral
replic
cellular
tropism
virus
well
induct
mediat
releas
host
tissu
use
origin
human
lung
tissu
particular
import
estim
actual
zoonot
potenti
emerg
furthermor
case
mer
coronaviru
meaning
anim
model
pneumococci
human
sole
natur
host
end
origin
viral
bacteri
strain
thereon
base
mutant
indispens
model
assess
impact
differ
strain
specif
virul
factor
pathogen
replic
tissu
infect
well
result
new
pharmacolog
intervent
rang
antivir
antibiot
host
manipul
test
well
recurr
infect
consid
import
factor
copd
thu
research
compar
effect
infect
ali
cultur
deriv
healthi
human
copd
alter
lung
epitheli
function
pcl
ali
cultur
toxic
inhal
pollut
cigarett
smoke
diesel
exhaust
also
expand
area
research
origin
human
materi
copd
studi
rang
observ
acut
effect
investig
epitheli
dedifferenti
mesenchym
studi
relat
focu
investig
toxic
potenti
inhal
substanc
human
lung
tissu
per
comparison
result
obtain
origin
human
materi
result
anim
model
great
import
estim
valid
data
respect
model
human
popul
fewer
studi
base
human
materi
anim
investig
lung
vitro
model
solid
tumor
vari
complex
furthermor
silico
model
system
analyz
ct
scan
improv
cancer
may
use
model
futur
drug
efficaci
test
mimic
eg
tumor
invas
relat
process
matrix
remodel
investig
hand
studi
use
origin
human
tissu
patient
thu
far
overal
briefli
review
exampl
alreadi
indic
model
great
valu
lung
research
despit
sever
advantag
highlight
propos
ex
vivoin
vitro
approach
clear
limit
need
consid
care
exampl
reproduc
experi
ex
vivo
model
alway
straightforward
access
lung
tissu
ex
vivo
highli
limit
tissu
section
mostli
obtain
individu
underli
diseas
rais
challeng
studi
potenti
alter
baselin
due
primari
diseas
major
drawback
model
poor
standard
hamper
reproduc
well
lack
complex
howev
challeng
standard
differ
approach
may
also
yield
complementari
inform
numer
public
report
novel
tissu
model
reli
differ
protocol
publish
suffici
inform
complet
independ
reproduc
result
moreov
vari
cellscel
line
scaffold
cell
cultur
media
use
complic
transfer
anoth
major
obstacl
lack
complex
organ
model
although
current
state
art
includ
two
even
cell
model
complex
live
tissu
vivo
yet
complet
emul
ex
vivo
similarli
vascular
system
distribut
immun
respons
well
tissu
regener
yet
possibl
model
consid
aspect
anim
model
remain
use
complementari
approach
although
predict
power
limit
distinct
differ
use
rais
ethic
concern
notabl
preclin
research
exclus
reli
model
system
advantag
limit
consid
care
choos
complementari
approach
could
help
improv
predict
power
preclin
research
significantli
reduc
number
anim
test
time
although
model
base
origin
human
materi
alreadi
consider
contribut
further
understand
human
lung
biolog
diseas
clear
sever
aspect
need
improv
near
futur
model
base
experi
singl
laboratori
hamper
standard
although
appli
mani
area
biomed
research
particular
import
undertaken
investig
endeavor
clinic
translat
relev
regulatori
author
ask
clear
descript
robust
model
standard
oper
procedur
make
model
accept
beyond
use
basic
scienc
addit
usabl
specif
model
compar
altern
anim
model
need
investig
detail
accept
compet
author
pharmaceut
industri
experiment
approach
consider
contribut
speed
translat
process
reduc
use
anim
biomed
scienc
therefor
donor
scientif
journal
need
encourag
scientif
commun
support
methodolog
improv
standard
project
beyond
standard
specif
scientif
challeng
exampl
way
extend
cultur
time
explant
lung
tissu
cultur
pcl
need
allow
investig
longer
last
process
human
lung
end
implement
lung
explant
cultur
microfluid
might
improv
tissu
nutrit
cultur
durat
microfluid
system
also
instrument
investig
interact
lung
organ
eg
axi
induc
physic
forc
breath
lung
chip
particular
import
addit
function
immun
system
microfluid
system
one
biggest
advantag
model
accompani
great
challeng
research
face
problem
gain
mechanist
answer
structur
built
differ
cell
type
time
one
key
method
therefor
develop
live
tissu
microscopi
techniqu
unfortun
classic
microscopi
signific
advantag
live
lung
tissu
compar
confoc
due
strong
light
scatter
chamber
alveolar
system
limit
techniqu
next
lung
tissu
strong
hamper
specif
fluoresc
signal
separ
therefor
method
must
combin
spectral
develop
fast
lattic
light
sheet
show
advantag
spectral
imag
demonstr
two
exampl
illustr
spectral
microscopi
linear
unmix
provid
possibl
overcom
high
tissu
allow
even
subcellular
resolut
complex
cellular
composit
human
alveolu
kind
imag
techniqu
drastic
improv
methodolog
potenti
visual
differ
cellular
structur
aspect
live
lung
tissu
model
gener
figur
innov
live
cell
label
combin
use
viral
transduct
system
gene
edit
allow
mechanist
analysi
lung
tissu
model
rapid
develop
stem
cell
base
decellular
procedur
tissu
make
build
relat
tissu
piec
use
basic
scienc
realist
within
next
year
overal
although
complex
development
step
need
overcom
alreadi
fascin
outlook
futur
human
pulmonari
model
experiment
translat
research
summar
matrix
figur
matrix
illustr
differ
requir
differ
type
human
pulmonari
model
also
give
overview
techniqu
come
focu
need
improv
adequ
analyz
model
one
central
goal
make
human
lung
stand
alon
model
integr
allow
physiolog
model
par
exceed
classic
wide
accept
vivo
anim
model
effort
combin
high
qualiti
cultur
techniqu
lung
substanti
increas
expans
method
scientif
commun
pharmaceut
industri
exchang
experi
detail
public
protocol
first
step
improv
futur
work
model
